Clinical Trials List
2026-02-23 - 2029-04-23
Phase I
Recruiting2
ICD-10C69.40
Malignant neoplasm of unspecified ciliary body
ICD-10C69.41
Malignant neoplasm of right ciliary body
ICD-10C69.42
Malignant neoplasm of left ciliary body
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9190.0
Malignant neoplasm of eyeball, except conjunctiva, cornea, retina and choroid
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Kun-Huei Yeh Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- 徐偉勛 醫學研究部
- 吳宗哲 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- San-Chi Chen Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- 唐振育 Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- Hao-Wei Teng Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
- 邱乃祈 Division of Radiology
- Yi-Ping Hung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
464 participants
